Print

Juvaris BioTherapeutics is a new biotechnology company, started in February, 2003, that is developing potent active immunotherapeutic vaccines. Active immunotherapy involves the activation of the patient's own Immune system to combat disease as opposed to passive immunotherapy utilizing administration of preformed monocional antibodies.

Industry News

Drug Discovery News; High-Value Vaccine Investment — August 2009
Nature Biotechnology; Biotech for your Companion? — December 2007
Forbes/Wolfe Emerging Tech Report; Technology Trends to Watch in 2008 — December 2007
StartUp Magazine; Juvaris BioTherapeutics, Inc. - Immune system booster and vaccine adjuvant — June 2007


About Us \| Technology Platform \| Pipeline \| Collaborators \| News & Presentations \| Careers \| Contact \| Site Map \| Home	Terms of Use \| Legal \| Site Users Guide © 2010 Juvaris BioTherapeutics.

© 2010 Juvaris BioTherapeutics.